Medicines and Poisons (Medicines) Regulation 2021
sec.162Record keeping for pseudoephedrine
Start here
Get a plain-English read of sec.162
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sec.162 Record keeping for pseudoephedrine
This section applies in relation to an S3 medicine containing pseudoephedrine. As soon as practicable after selling the medicine, a pharmacist must make and keep a record of the following information— the date of the sale; the name of the medicine; the amount of the medicine sold; the name and address of the person who bought the medicine; the type of document used to identify the person who bought the medicine and an identifier for the document, if applicable. driver licence number, passport number The record must be kept electronically in a way that complies with the departmental standard called ‘Pseudoephedrine recording’. (sec.162-ssec.1) This section applies in relation to an S3 medicine containing pseudoephedrine. (sec.162-ssec.2) As soon as practicable after selling the medicine, a pharmacist must make and keep a record of the following information— the date of the sale; the name of the medicine; the amount of the medicine sold; the name and address of the person who bought the medicine; the type of document used to identify the person who bought the medicine and an identifier for the document, if applicable. driver licence number, passport number (sec.162-ssec.3) The record must be kept electronically in a way that complies with the departmental standard called ‘Pseudoephedrine recording’.
- (a) the date of the sale;
- (b) the name of the medicine;
- (c) the amount of the medicine sold;
- (d) the name and address of the person who bought the medicine;
- (e) the type of document used to identify the person who bought the medicine and an identifier for the document, if applicable. Examples for paragraph (e) — driver licence number, passport number